Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cardioprotective effects of new antioxidant discussed at Kyoto meeting

April 9, 2001

Second-line antihypertensive combination therapy launched in U.S.

April 6, 2001

Senju prepares new chymase inhibitor series for use in cardiovascular disorders

April 3, 2001

Comprehensive review of Natrecor published in prestigious journal

April 3, 2001

Novel cardiovascular drugs sought by MediGene and Evotec BioSystems

April 3, 2001

ACS news: A-292438 as a promising ETA-selective antagonist

April 2, 2001

Autologous bone marrow cell implantation: a novel strategy for optimizing therapeutic angiogenesis

April 2, 2001

Promising data reported from phase I trial of Esperion's ApoA-I Milano

April 2, 2001

Curis begins clinical evaluation of Vascugel in coronary artery disease

April 2, 2001

Potassium channel blockers targeting the slow delayed rectifier designed by Merck

March 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...